Trials / Recruiting
RecruitingNCT06566560
The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
Cost-savings and Environmental Impact Obtained From Redispensing Unused Oral Anticancer Drugs
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,500 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs. The main questions it aims to answer are: * What are the cost-savings of redispensing unused oral anticancer drugs? * What is the environmental impact of redispensing unused oral anticancer drugs? Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal. Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | redispensing oral anticancer drugs | Participants will receive oral anticancer drugs according to their regular prescriptions, distributed in the original manufacturer's package. Following the guideline, some oral anticancer drug (i.e. requiring temperature storage up to 25C degrees) will be supplemented with a validated temperature indicator (Timestrip Neo, customer configuration), enclosed with a seal bag. Patients are requested to return unused oral anticancer drugs to the outpatient pharmacy that distributed them. Pharmacy staff will assess the quality of returned oral anticancer drugs, applying the following criteria: 1. the seal bag is unopened 2. the drug package is unopend and undamaged 3. the expiry date is ≥ 3 months 4. the medication has not been stored outside the product label storage claim Oral anticancer drugs that meet all criteria are restocked, and consecutively redispensed to participants visiting the same outpatient pharmacy. |
Timeline
- Start date
- 2024-01-10
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-08-22
- Last updated
- 2024-08-22
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06566560. Inclusion in this directory is not an endorsement.